CIK: 0001731118
Total reported value
$1.7B
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | STLA | Stellantis N.V. | Stock-Consumer Disc | 88.43% | -8.68% | — | |
| 2 | CSTM | Constellium SE | Stock-Other | 7.25% | — | — | |
| 3 | CRTO | Criteo Sa-spon Adr | Stock-Other | 2.87% | — | — | |
| 4 | ✓ | Vectivbio Holding | Stock-Other | 0.76% | — | — | |
| 5 | ✓ | Stock-Other | 0.46% | — | — | ||
| 6 | ✓ | Cellectis S A | Stock-Other | 0.15% | — | — | |
| 7 | FTI | TechnipFMC plc | Stock-Energy | 0.05% | — | -99.10% | |
| 8 | CRSP | CRISPR Therapeutics AG | Stock-Healthcare | 0.02% | — | -40.00% |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | STLA | Stellantis N.V. | — | EXIT | Sold out |
| 2 | CSTM | Constellium SE | — | EXIT | Sold out |
| 3 | FTI | TechnipFMC plc | — | EXIT | Sold out |
| 4 | CRTO | Criteo Sa-spon Adr | — | EXIT | Sold out |
| 5 | ✓ | — | EXIT | Sold out | |
| 6 | ✓ | Cellectis S A | — | EXIT | Sold out |
| 7 | CRSP | CRISPR Therapeutics AG | — | EXIT | Sold out |